WATSON 415
Pill imprint WATSON 415 has been identified as Estropipate 1.5 mg.
Estropipate is used in the treatment of oophorectomy; atrophic vaginitis; atrophic urethritis; primary ovarian failure; postmenopausal symptoms (and more), and belongs to the drug class estrogens. Not for use in pregnancy.
Estropipate 1.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Estropipate Images
- Imprint:
-
WATSON 415
- Strength:
- 1.5 mg
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Estrogens
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
Advertisement
More Estropipate resources
- Estropipate (Wolters Kluwer)
- estropipate (Cerner Multum)
- Estropipate (FDA)
- Estropipate (Piperazine Estrone Sulfate) (Wolters Kluwer)
Search Again
